癌症患者活动性结核风险:系统综述与荟萃分析
美国6项研究(317243例)显示1980年后血液系统肿瘤活动性结核CIR最高(219/100000,IRR=26),头颈癌(143;16)和肺癌(83;9)次之,乳腺癌及其他实体瘤最低(38;4)。
要点
- 美国血液系统、头颈和肺癌患者活动性结核发生率约为无癌人群的9倍。
- 1980年后血液系统肿瘤活动性结核CIR为219/100000,IRR=26。
- 头颈癌和肺癌活动性结核CIR分别为143/100000(IRR=16)和83/100000(IRR=9)。
核心结论
- 美国血液系统、头颈和肺癌患者活动性结核发生率显著高于无癌人群,约高9倍,可从针对性潜伏结核筛查和治疗中获益。
研究设计与样本
- 共纳入23项研究,报告1950至2011年间324041例癌症患者中593例结核病例。
- 对6项美国研究(317243例癌症患者,占全部患者98%)进行累积发病率和发病率比的随机效应荟萃分析。
主要发现
- 1980年前后,血液系统肿瘤和实体瘤患者活动性结核CIR分别下降3倍和6.5倍。
- 1980年后血液系统肿瘤活动性结核CIR为219/100000(IRR=26)。
- 1980年后头颈癌活动性结核CIR为143/100000(IRR=16),肺癌为83/100000(IRR=9)。
- 1980年后乳腺癌及其他实体瘤活动性结核CIR最低,为38/100000(IRR=4)。
临床怎么用
- 对血液系统肿瘤、头颈癌和肺癌患者,考虑进行针对性潜伏结核筛查。
- 对筛查阳性者考虑潜伏结核治疗,以降低活动性结核风险。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Cancer is a known risk factor for developing active tuberculosis (TB). We determined the incidence and relative risk of active TB in cancer patients compared to the general population. METHODS: Electronic databases were searched up to December 2015: Medline, Medline InProcess, EMBASE, PubMed, the Cochrane Database of Systematic Reviews, Cancerlit, and Web of Science. Studies of pathologically confirmed cancer patients were included if active TB was identified concurrently or after the diagnosis. Cumulative incidence rate/100,000 population (CIR) of new cases of TB occurring in cancer patients and comparative incidence rate ratios (IRR) to the general population from the same country of origin were estimated. A random effect meta-analysis was conducted on the CIR and IRR. RESULTS: A total of 23 studies reporting 593 TB cases occurring in 324,041 cancer patients between 1950 and 2011 were identified. In a meta-analysis of 6 studies conducted in the US in 317,243 cancer patients (98% of all patients) the CIR of active TB decreased by 3 fold and 6.5 fold in hematologic and solid cancers respectively before and after 1980. After 1980 the CIR of active TB was highest in hematologic (219/100,000 population, IRR=26), head and neck (143; 16), lung cancers (83; 9) and was lowest in breast and other solid cancers (38; 4). CONCLUSIONS: Individuals living in the US with hematologic, head and neck, and lung cancers had a 9-fold higher rate of developing active TB compared to those without cancer and would benefit from targeted latent TB screening and therapy.
引用
- Cheng MP, Abou Chakra CN, Yansouni CP, et al. Risk of Active Tuberculosis in Patients with Cancer: A Systematic Review and Meta-Analysis. Clin Infect Dis. 2016. PMID: 27986665
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。